This multiple coupling may be a differentiating advantage for the GPR39 target within the field of diabetes versus GPCRs with a more restricted coupling, e. g. GPR40 (mainly Gαq/11) [25] and GPR119 (mainly Gαs) [26]. This evidence concerns the gene FFAR1 and diabetes mellitus.